Hypertrophic Cardiomyopathy is a not an uncommon heart disease. Recent publications indicate that HCM is the most common of all genetic heart conditions affecting 1 in 500 people in the general population. Based on these data we may estimate that as many as 600,000 people in the United States have HCM. Subsequent studies have also proven that HCM has a prevelance of 1 in 500 in a wide variety of populations including, Native Americans, Chinese, Rural Midwestern US, and others. There is no gender, age or ethnic factor specific to HCM, HCM is an equal oppertunity disease.
In comparison Cystic Fibrosis has a prevalence of 1 in 3300. This means HCM is nearly 7 times more common than Cystic Fibrosis.
If you would like to help the HCMA spread the word about this condition, please contact our office 973-983-7429.
Maron, B.J. and Salberg, L. Hypertrophic Cardiomyopathy: For patients, their families and interested physicians. Blackwell Futura: 1st edition 2001,81 pages; 2nd edition 2006, 113 pages; 3rd edition pending publication 2014
Gersh, B.J., Maron, B.J., Bonow, R.O., Dearani, J.A., Fifer, M.A., Link, M.S., et al. (2011). 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation/American Heart Asociation Task Force on practice guidelines. Journal of the American College of Cardiology and Circulation, 58, e212-260.
Maron BJ.Hypertrophic cardiomyopathy in China. Am J Cardiol. 2007 Jul 1;100(1):145-6. Epub 2007 May 21
Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005 Aug 2;46(3):480-7.
Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.J Am Coll Cardiol. 2004 Dec 7;44(11):2125-32.